Anagenics Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was AUD 5.15 million compared to AUD 3.22 million a year ago. Net loss was AUD 1.46 million compared to AUD 1.75 million a year ago.

Basic loss per share from continuing operations was AUD 0.0024 compared to AUD 0.0053 a year ago. Diluted loss per share from continuing operations was AUD 0.0024 compared to AUD 0.0053 a year ago. Basic loss per share was AUD 0.0066 compared to AUD 0.0089 a year ago.

Diluted loss per share was AUD 0.0066 compared to AUD 0.0089 a year ago.